Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2011-04-27

Original market date: See footnote 1

1994-12-31

Product name:

ORFENACE TABLET 100MG

DIN:

02047535 Electronic product monograph is not available

Company: 

STERIMAX INC
2770 Portland Drive
Oakville
Ontario
Canada  L6H 6R4

Class: 

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

OTC  

American Hospital Formulary Service (AHFS): See footnote 3

12:20.92   MISCELLANEOUS SKELETAL MUSCLE RELAXANTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

M03BC01  ORPHENADRINE (CITRATE)

Active ingredient group (AIG) number:See footnote 5

0102078001

List of active ingredient(s)
Active ingredient(s) Strength
ORPHENADRINE CITRATE 100 MG

Application information

Related information

Contact us

Date modified: